ODYSSEY to be presented at CROI 2020

Results from the ODYSSEY trial will be presented at this year’s Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, USA. The trial team’s abstract titled “Adequate dolutegravir exposure dosed bid with rifampicin in children 6 to <18 years” has...
ODYSSEY: recruitment has completed!

ODYSSEY: recruitment has completed!

ODYSSEY: recruitment has completed! We are pleased to announce that recruitment to the main trial has now completed. We have recruited slightly more than the total target of 700 participants: 312 recruited into ODYSSEY A (naïve to HIV treatment) and 396 into ODYSSEY B...